• Mithramycin A: Precision Control in Transcription and Differ

  2026-08-04

  Explore how Mithramycin A, a potent anticancer antibiotic, enables precise modulation of gene expression and myeloid differentiation in research. This in-depth analysis reveals unique mechanistic and protocol insights for advancing leukemia and cancer biology studies.

• Cimetidine: Breaking Barriers in Translational GI Cancer Res

  2026-08-03

  Explore how Cimetidine’s distinct pharmacology as a histamine-2 receptor antagonist and partial agonist is redefining experimental strategies at the interface of gastrointestinal cancer and CNS drug development. This article offers mechanistic insight, actionable protocol guidance, and a strategic roadmap for translational researchers using validated high-throughput models and cutting-edge solutions from APExBIO.

• Advancing Mitochondrial Dysfunction Research with TMRE Assay

  2026-08-03

  Explore how Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) empowers translational researchers to dissect mitochondrial membrane potential and oxidative stress mechanisms, with strategic integration of mechanistic findings on trichothecene-induced mitochondrial dysfunction. This article bridges advanced live-cell imaging workflows with emerging disease models, offering actionable protocol guidance and a vision for leveraging mitochondrial membrane potential assays in toxicology and therapeutic discovery.

• Biomimetic Chromatography Advances Pulmonary Drug Permeabili

  2026-08-02

  This study benchmarks biomimetic open tubular capillary electrochromatography and immobilised artificial membrane chromatography, both coupled with mass spectrometry, to model lung permeability of pharmaceuticals. The findings provide high-throughput, robust alternatives to conventional partitioning metrics, with implications for streamlining respiratory drug development.

• Photothermal Therapy and CD47 Blockade Synergy in OSCC

  2026-08-01

  This study demonstrates that combining photothermal therapy (PTT) with CD47 immune checkpoint blockade in oral squamous cell carcinoma (OSCC) robustly enhances macrophage-mediated tumor clearance. The innovation lies in showing how PTT induces calreticulin exposure and remodels the extracellular matrix, overcoming immune evasion and physical barriers to immunotherapy.

• ML133 HCl: Advanced Potassium Channel Inhibitor for Kir2.1 S

  2026-07-31

  ML133 HCl delivers high selectivity and potency for Kir2.1 potassium channel inhibition, enabling precise dissection of pulmonary artery smooth muscle cell proliferation and migration. This guide translates the latest experimental breakthroughs into actionable protocols and troubleshooting strategies for cardiovascular ion channel research.

• KIF26B Downregulation Sensitizes Ovarian Cancer to Paclitaxe

  2026-07-31

  This study demonstrates that low KIF26B expression reduces paclitaxel resistance in ovarian cancer cells by modulating cell proliferation, apoptosis, and microtubule dynamics. The findings suggest KIF26B and its interplay with SLC7A11 as potential therapeutic targets to overcome chemoresistance in advanced ovarian cancer.

• Thermosensitive Hybrid Hydrogel Enhances Ocular Antibiotic D

  2026-07-30

  This study introduces a thermosensitive polyhedral oligomeric silsesquioxane (BPOSS) hybrid hydrogel for improved erythromycin delivery in bacterial keratitis. The hydrogel improves drug solubility, extends retention on the ocular surface, and demonstrates superior biocompatibility and antibacterial efficacy in vivo.

• GET3’s Role in MCL1 Tail-Anchoring and Apoptosis Regulation

  2026-07-30

  This study uncovers a previously uncharacterized role for the GET3 pathway in controlling the membrane insertion and stability of MCL1, a critical anti-apoptotic protein. The findings enhance our mechanistic understanding of how apoptosis is regulated during mitotic arrest, with direct implications for the use of MCL1 inhibitors in cancer research.

• Enhanced Lysosomal Exocytosis in MPS IVA Cartilage Pathology

  2026-07-29

  This study demonstrates that increased lysosomal exocytosis, coupled with altered growth factor signaling, underlies cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA (MPS IVA). The findings expand the understanding of lysosomal storage disorders by implicating lysosome-mediated membrane trafficking and protease mislocalization in skeletal disease pathogenesis.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-07-29

  This study uncovers a pyroptosis-independent mechanism by which Gasdermin C (GSDMC) enhances stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC). The findings indicate that targeting GSDMC or its cleavage/nuclear localization could improve therapeutic responses in PDAC, highlighting a new avenue for anti-cancer strategies.

• GSK2606414: Precision PERK Inhibitor for ER Stress Research

  2026-07-28

  GSK2606414 enables nanomolar-precision dissection of PERK-driven signaling in ER stress and pyroptosis models, with direct translational relevance for disc degeneration and cancer. This guide delivers actionable workflows, troubleshooting tactics, and unique insights from the latest mechanistic studies.

• EZH2 Inhibition in HPV-Driven Cervical Cancer: Insights from

  2026-07-28

  The referenced study systematically evaluates the therapeutic efficacy of EZH2 inhibitors, specifically EPZ-6438, in targeting HPV-associated cervical cancer. The findings highlight selective induction of apoptosis, cell cycle arrest, and restoration of tumor suppressor pathways, offering mechanistic and translational advances for epigenetic cancer research.

• AICAR Phosphate (Acadesine): Precision Apoptosis and CNS Imm

  2026-07-27

  Explore how AICAR phosphate (Acadesine) advances targeted apoptosis in B-cell chronic lymphocytic leukemia research and reveals new frontiers in central nervous system (CNS) immune modulation. This article connects AMPK activation with mitochondrial pathways and highlights assay decisions shaped by the latest mechanistic insights.

• Cardiogreen in Translational Science: Bridging Diagnostics a

  2026-07-27

  Cardiogreen (Indocyanine Green) epitomizes the fusion of molecular precision and translational promise, driving innovation across diagnostic and therapeutic domains. This article dissects the mechanistic underpinnings, experimental best practices, and strategic opportunities that Cardiogreen unlocks for research teams at the forefront of cardiovascular, hepatic, and oncology applications. By anchoring discussion in emerging literature and offering actionable protocol guidance, this piece delivers a uniquely actionable roadmap for translational scientists who seek to leverage Cardiogreen’s full spectrum of clinical and research utility.

449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page